Deerfield Management Company, L.P.
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital, Hedge Funds, Private Credit, Hedge Fund
Stage Focus
Seed, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed, Early Stage
Geographical Focus
United States, China, Qatar
Industries Focus
- Healthcare
- HealthTech
- Artificial Intelligence
- Life Sciences
- Healthcare Services
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Machine Learning
- Biotechnology
- Health Services
- Medical Research
- Medical Equipment
- Medical Technologies
Investor Details Founded: 1994
Deerfield Management Company, L.P. is an American investment firm headquartered in New York City, focused on advancing healthcare through investment, information, and philanthropy. Established in 1994, the firm manages over $15 billion in assets as of December 2024. Deerfield's mission is to cure disease, improve quality of life, and reduce the cost of care.
The firm employs a collaborative and pragmatic approach, leveraging operational expertise to navigate the complexities of the healthcare and financial industries. Deerfield offers flexible financing options tailored to the needs of entrepreneurs and corporate partners, supporting the development of compelling assets both independently and in partnership with strategic and corporate partners.
Deerfield's portfolio includes more than 200 private and public investments across the life sciences, medical device, diagnostic, digital health, and health services industries, encompassing all stages of company evolution from startup to mature enterprise. The firm also engages in philanthropic activities through the Deerfield Foundation, a New York City-based not-for-profit organization dedicated to improving health, accelerating innovation, and promoting human equity.
Requirements
- Focus on healthcare and biotechnology sectors
- Interest in both public and private companies
- Willingness to engage in various investment stages from seed to buyout
- Alignment with Deerfield's mission to advance healthcare through investment, information, and philanthropy
- Healthcare focus
- Innovative solutions
- Scalable business models
- Healthcare-focused companies
- Innovative therapeutics
- Advancements in healthcare delivery
- Emerging technologies with potential to shift existing paradigms
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- LetsGetChecked
- Pairwise Plants
- Frontier Medicines
- Element Science
- RubiconMD
- ConcertoCare
- Adaptive Phage Therapeutics
- TriNetX
- Contessa
- IMRIS
- Adeptus Health
- Melinta Therapeutics
- Nuvalent Inc
- Viatris
- Centene
- Neurocrine Biosciences
- Owens & Minor
- Sarepta Therapeutics Inc
- Cohere Health
- VeritaScience
- Medical Microinstruments
- Alo
- Bayfield Therapeutics
- Brookdale Senior Living
Mentioned In
-
$49.95
-
$14.95
-
$19.95
-
$39.95
-
$24.95
-
$19.95
-
$24.95
-
$299.00
-
$95.00
Claim this Investor
Are you an official representative of Deerfield Management Company, L.P.?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim